What is Advanced Pharma?
Headquartered in Miami, Advanced Pharma operates as a high-capacity clinical research organization with a legacy spanning over five decades of combined Phase I expertise. The company distinguishes itself through the execution of more than 150 clinical trials, leveraging a team of seasoned Physician Investigators to maintain rigorous scientific standards. By integrating advanced diagnostic tools such as onsite FibroScan technology, the firm provides specialized support for complex liver-related research, effectively bridging the gap between early-stage discovery and late-stage regulatory approval. Their market position is defined by a dual focus on high-quality data integrity and a participant-centric approach to clinical trial management.
How much funding has Advanced Pharma raised?
Advanced Pharma has raised a total of $429K across 2 funding rounds:
Debt
$150K
Debt
$279K
Debt (2020): $150K with participation from PPP
Debt (2021): $279K led by PPP
Key Investors in Advanced Pharma
PPP
Public-Private Partnership
What's next for Advanced Pharma?
With the successful acquisition of $279K, Advanced Pharma is well-positioned to accelerate its strategic roadmap, focusing on the modernization of its clinical trial facilities and the enhancement of its diagnostic service portfolio. The company is expected to leverage this capital to increase its throughput for late-phase studies, thereby attracting larger pharmaceutical partnerships. As the clinical research sector continues to demand higher precision and faster turnaround times, Advanced Pharma's investment in specialized diagnostic infrastructure will likely serve as a key competitive differentiator. Future growth will likely center on expanding its therapeutic focus areas and deepening its integration with global pharmaceutical pipelines, ensuring sustained relevance in an increasingly complex regulatory environment.
See full Advanced Pharma company page
